ProCE Banner Activity

Slides on Key Decisions in HIV Care: Choosing ART in the Context of Virologic Failure and Resistance

Slideset Download
Learn key considerations when choosing ART for patients with virologic failure and resistance, including how to build an optimized background regimen and the data to support the inclusion of novel therapies into ART regimens.

Released: November 29, 2021

Expiration: November 28, 2022

Share

Faculty

W. David Hardy

W. David Hardy, MD

Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Josep M. Llibre

Josep M. Llibre, MD, PhD

Senior Consultant
Infectious Diseases Division
Fight Infections Foundation
University Hospital Germans Trias
Badalona, Barcelona, Spain

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

W. David Hardy, MD

Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Josep M. Llibre, MD, PhD

Senior Consultant
Infectious Diseases Division
Fight Infections Foundation
University Hospital Germans Trias
Badalona, Barcelona, Spain